1	Female subjects of nonchildbearing potential premenarcheal postmenopausal for at least 2 years bilateral oophorectomy or tubal ligation and complete hysterectomy are eligible Female subjects of childbearing potential are eligible if they use medically accepted contraceptive methods Oral or depot contraceptive|contraceptive[261,274]|||||Oral[283,287]||2 years[87,94]|||64078|64078|contraceptive
1	Female subjects of nonchildbearing potential premenarcheal postmenopausal for at least 2 years bilateral oophorectomy or tubal ligation and complete hysterectomy are eligible Female subjects of childbearing potential are eligible if they use medically accepted contraceptive methods Oral or depot contraceptive|contraceptive[297,310]||||||||||64078|64078|contraceptive
2	treatment with at least ethinylestradiol 30 ?g per intake used with an additional barrier contraception method monogamous relationship with vasectomized or female partner or double-barrier contraception are acceptable methods The subject must understand the consequences and potential risks of inadequately|ethinylestradiol[335,351]|||30[352,354]|||||||4124|4124|ethinylestradiol
3	protected sexual activity be educated about and understand the proper use of contraceptive methods and undertake to inform the Investigator of any potential change in status Abstinence will be considered as an acceptable method of contraception if the Investigator can document that the subject agrees|contraceptive[695,708]||||||||||64078|64078|contraceptive
